FIBROBIOLOGICS INC (FBLG) Forecast, Price Target & Analyst Ratings

NASDAQ:FBLG • US31573L1052

Current stock price

0.1966 USD
-0.02 (-10.64%)
At close:
0.1989 USD
+0 (+1.17%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for FIBROBIOLOGICS INC (FBLG).

Forecast Snapshot

Consensus Price Target

Price Target
N/A
N/A
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.07
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.22%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
N/A
Upside
N/A
From current price of $0.20 to mean target of N/A, Based on 9 analyst forecasts
Low
N/A
Median
N/A
High
N/A

Price Target Revisions

1 Month
0.00%
3 Months
-20.00%

Price Target Summary

The average price target has been revised downward by 20% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

FBLG Current Analyst RatingFBLG Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

FBLG Historical Analyst RatingsFBLG Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
82.22%
FBLG was analyzed by 9 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about FBLG.
In the previous month the buy percentage consensus was at a similar level.
FBLG was analyzed by 9 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-26D. Boral CapitalDowngrade Buy -> Hold
2026-03-12D. Boral CapitalMaintains Buy -> Buy
2026-02-26HC Wainwright & Co.Maintains Buy -> Buy
2026-02-25D. Boral CapitalMaintains Buy -> Buy
2026-01-06D. Boral CapitalMaintains Buy -> Buy
2026-01-02HC Wainwright & Co.Reiterate Buy -> Buy
2025-11-20D. Boral CapitalMaintains Buy -> Buy
2025-11-05HC Wainwright & Co.Maintains Buy -> Buy
2025-11-03D. Boral CapitalMaintains Buy -> Buy
2025-09-12HC Wainwright & Co.Reiterate Buy -> Buy
2025-09-10D. Boral CapitalMaintains Buy -> Buy
2025-08-05HC Wainwright & Co.Maintains Buy -> Buy
2025-08-04D. Boral CapitalMaintains Buy -> Buy
2025-07-29D. Boral CapitalMaintains Buy -> Buy
2025-07-09D. Boral CapitalMaintains Buy -> Buy
2025-06-17D. Boral CapitalMaintains Buy -> Buy
2025-05-15D. Boral CapitalMaintains Buy -> Buy
2025-04-09D. Boral CapitalMaintains Buy -> Buy
2025-04-01D. Boral CapitalMaintains Buy -> Buy
2025-04-01HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-04D. Boral CapitalMaintains Buy -> Buy
2025-02-27D. Boral CapitalMaintains Buy -> Buy
2025-02-13D. Boral CapitalMaintains Buy -> Buy
2025-02-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-12-27D. Boral CapitalMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q1 / 2026
EPS Estimate
-$0.07
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
51.43%
Number of Analysts
6

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
25.92%
EPS (3 Months)
33.33%

Next Earnings Summary

FBLG is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.07 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
FBLG revenue by date.FBLG revenue by date.
N/AN/AN/AN/AN/A
1,066.83%		N/A
179.34%		N/A
85.45%		N/A
74.42%
EBITDA
YoY % growth
FBLG ebitda by date.FBLG ebitda by date.
N/AN/A-8.842M-13.58M
-53.59%		-16.405M
-20.80%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
FBLG ebit by date.FBLG ebit by date.
-1.578M-4.467M
-183.08%		-8.889M
-98.99%		-13.737M
-54.54%		-16.649M
-21.20%		N/A
-31.16%		N/A
-28.06%		N/A
-24.54%		N/A
-35.06%		N/A
103.35%		N/A
6,793.27%		N/A
150.29%		N/A
100.89%
Operating Margin
FBLG operating margin by date.FBLG operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
FBLG eps by date.FBLG eps by date.
N/AN/AN/AN/A-0.42
-21.11%		N/A
40.50%		N/A
-9.18%		N/A
-6.54%		N/A
-47.37%		N/A
48.81%		N/A
176.74%		N/A
360.61%		N/A
119.08%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.07
51.43%		-0.05
54.67%		-0.05
58.16%		-0.06
-104.00%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-5.144M
-13.54%		-5.217M
-16.20%		-5.557M
-10.30%		-5.918M
-128.48%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

FBLG Yearly Revenue VS EstimatesFBLG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 200M 400M 600M
FBLG Yearly EPS VS EstimatesFBLG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 0.5 1 1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
9.36%
EPS Next 5 Year
8.13%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

FIBROBIOLOGICS INC / FBLG Forecast FAQ

Can you provide the upcoming earnings date for FIBROBIOLOGICS INC?

FIBROBIOLOGICS INC (FBLG) will report earnings on 2026-05-12.

What are the consensus estimates for FIBROBIOLOGICS INC (FBLG) next earnings?

The consensus EPS estimate for the next earnings of FIBROBIOLOGICS INC (FBLG) is -0.07 USD and the consensus revenue estimate is 0 USD.